UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uptake of Nitrobenzylthioinosine and Purine β-l-Nucleosides by Intracellular Toxoplasma gondii

Antimicrobial Agents and Chemotherapy, 2003-10, Vol.47 (10), p.3247-3251

2003

Volltextzugriff (PDF)

Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine

Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2015-10, Vol.188, p.63-69

2015

Volltextzugriff (PDF)

Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents

Biochemical pharmacology, 2007-05, Vol.73 (10), p.1558-1572

2007

Volltextzugriff (PDF)

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2437-2443

1999

Volltextzugriff (PDF)

Synthesis, biological evaluation and molecular modeling studies of N-benzyladenosine analogues as potential anti-toxoplasma agents

Biochemical pharmacology, 2007-05, Vol.73 (10), p.1558-1572

2007

Volltextzugriff (PDF)

Structure–activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase

Bioorganic & medicinal chemistry, 2010-05, Vol.18 (10), p.3403-3412

2010

Volltextzugriff (PDF)

7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities

Biochemical pharmacology, 2008-10, Vol.76 (8), p.958-966

2008

Volltextzugriff (PDF)

Structure−Activity Relationships of 7-Deaza-6-benzylthioinosine Analogues as Ligands of Toxoplasma gondii Adenosine Kinase

Journal of medicinal chemistry, 2008-07, Vol.51 (13), p.3934-3945

2008

Volltextzugriff (PDF)

Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: Biological activities and selective toxicities

Biochemical pharmacology, 2010-10, Vol.80 (7), p.955-963

2010

Volltextzugriff (PDF)

Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity

Cancer chemotherapy and pharmacology, 2012-06, Vol.69 (6), p.1449-1455

2012

Volltextzugriff (PDF)

5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability : Relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens

Cancer chemotherapy and pharmacology, 2005-06, Vol.55 (6), p.541-551

2005

Volltextzugriff (PDF)

6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities

Biochemical pharmacology, 2005-05, Vol.69 (10), p.1409-1419

2005

Volltextzugriff (PDF)

Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of Toxoplasma gondii Adenosine Kinase

Journal of medicinal chemistry, 2004-04, Vol.47 (8), p.1987-1996

2004

Volltextzugriff (PDF)

Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor

Cancer chemotherapy and pharmacology, 2006-11, Vol.58 (5), p.692-698

2006

Volltextzugriff (PDF)

Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of Toxoplasma g ondii Adenosine Kinase

Journal of medicinal chemistry, 2004-04, Vol.47 (8), p.1987-1996

2004

Volltextzugriff (PDF)

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Biochemical pharmacology, 2000-09, Vol.60 (6), p.851-856

2000

Volltextzugriff (PDF)

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

Biochemical pharmacology, 2000-08, Vol.60 (3), p.427-431

2000

Volltextzugriff (PDF)

Synthesis, biological evaluation and molecular modeling studies of N 6-benzyladenosine analogues as potential anti-toxoplasma agents

Biochemical pharmacology, 2007-05, Vol.73 (10), p.1558-1572

2007

Volltextzugriff (PDF)

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy

Cancer chemotherapy and pharmacology, 2001-11, Vol.48 (5), p.389-397

2001

Volltextzugriff (PDF)

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

Bioorganic & medicinal chemistry letters, 1999-06, Vol.9 (11), p.1477-1480

1999

Volltextzugriff (PDF)

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.351-361

2000

Volltextzugriff (PDF)

Uptake of nitrobenzylthioinosine and purine β-L-nudeosides by intracellular Toxoplasma gondii

Antimicrobial agents and chemotherapy, 2003, Vol.47 (10), p.3247-3251

2003

Volltextzugriff (PDF)

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

Cancer chemotherapy and pharmacology, 2001-08, Vol.48 (2), p.145-150

2001

Volltextzugriff (PDF)

ChemInform Abstract: Uridine Phosphorylase Inhibitors: Chemical Modification of Benzyloxybenzyl-barbituric Acid and Its Effects on UrdPase Inhibition

ChemInform, 1999-09, Vol.30 (36), p.no-no

1999

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Pharmacology & Pharmacy
(18)
Animals
(17)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(15)
Chemotherapy
(12)
Mice
(11)
Humans
(10)
Female
(9)
Toxoplasma - Enzymology
(9)
Adenosine Kinase - Metabolism
(8)
Thioinosine - Analogs & Derivatives
(8)
Uridine Phosphorylase - Antagonists & Inhibitors
(8)
Toxoplasmosis
(7)
5-Acyclouridine
(6)
Antineoplastic Agents
(6)
Enzyme Inhibitors - Pharmacology
(6)
Oncology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Uptake of Nitrobenzylthioinosine and Purine β-l-Nucleosides by Intracellular Toxoplasma gondii

Kinetic mechanism of Toxoplasma gondii adenosine kinase and the highly efficient utilization of adenosine

Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Synthesis, biological evaluation and molecular modeling studies of N-benzyladenosine analogues as potential anti-toxoplasma agents

Structure–activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase

7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities

Structure−Activity Relationships of 7-Deaza-6-benzylthioinosine Analogues as Ligands of Toxoplasma gondii Adenosine Kinase

Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: Biological activities and selective toxicities

Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity

5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability : Relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens

6-Benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: Activities and selective toxicities

Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of Toxoplasma gondii Adenosine Kinase

Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor

Synthesis, Biological Activity and Molecular Modeling of 6-Benzylthioinosine Analogues as Subversive Substrates of Toxoplasma g ondii Adenosine Kinase

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

Synthesis, biological evaluation and molecular modeling studies of N 6-benzyladenosine analogues as potential anti-toxoplasma agents

Enhancement of the bioavailability of oral uridine by coadministration of 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for uridine rescue regimens in chemotherapy

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Uptake of nitrobenzylthioinosine and purine β-L-nudeosides by intracellular Toxoplasma gondii

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

ChemInform Abstract: Uridine Phosphorylase Inhibitors: Chemical Modification of Benzyloxybenzyl-barbituric Acid and Its Effects on UrdPase Inhibition

Suchergebnisse filtern